Unraveling the Place of Small Molecules in theTreatment of Fistulizing Crohn’s Disease—A Systematic Review and Network Meta-Analysis
Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › fagfællebedømt
Dokumenter
- Fulltext
Forlagets udgivne version, 144 KB, PDF-dokument
Originalsprog | Engelsk |
---|---|
Artikelnummer | otad074 |
Tidsskrift | Crohn's and Colitis 360 |
Vol/bind | 5 |
Udgave nummer | 4 |
Antal sider | 2 |
DOI |
|
Status | Udgivet - 2023 |
Bibliografisk note
Funding Information:
M.A., D.N.R., and F.O.B report no conflicts of interest. J.B. reports grants and personal fees from AbbVie, grants and personal fees from Janssen-Cilag, personal fees from Celgene, grants and personal fees from MSD, personal fees from Pfizer, grants and personal fees from Takeda, grants and personal fees from Tillots Pharma, personal fees from Samsung Bioepis, grants, and personal fees from Bristol Myers Squibb, grants from Novo Nordisk, personal fees from Pharmacosmos, personal fees from Ferring, personal fees from Galapagos, outside the submitted work. J.B.S. has received research grants from Takeda, Janssen and is the national coordinator of studies from AbbVie, Arena Pharmaceuticals, Ely Lilly, and Boehringer Ingelheim. None of these pertain to the research submitted here.
ID: 387034961